Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Sundry Debtors

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹1,538 Cr₹848 Cr₹576 Cr₹388 Cr₹331 Cr

What is the latest Sundry Debtors ratio of MANKIND PHARMA ?

The latest Sundry Debtors ratio of MANKIND PHARMA is ₹1,538 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹1,538 Cr
Mar2024₹848 Cr
Mar2023₹576 Cr
Mar2022₹388 Cr
Mar2021₹331 Cr

How is Sundry Debtors of MANKIND PHARMA Trending?

Years Sundry Debtors % Change
Mar2025 ₹1,538 Cr
81.35
Mar2024 ₹848 Cr
47.16
Mar2023 ₹576 Cr
48.50
Mar2022 ₹388 Cr
17.41
Mar2021 ₹331 Cr -

Compare Sundry Debtors of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹100,552.3 Cr -6.2% -3.1% 23.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,917.0 Cr -3.3% -4.6% -7.9% Stock Analytics
DIVIS LABORATORIES ₹158,982.0 Cr -9% -13.6% 24% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,306.0 Cr -1.1% 7% 8.2% Stock Analytics
CIPLA ₹121,442.0 Cr -2% 0.6% -4% Stock Analytics
DR REDDYS LABORATORIES ₹101,752.0 Cr -1.1% -3.8% -13.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.2%

-3.1%

23.6%

SENSEX

-0.9%

-4.4%

1.6%


You may also like the below Video Courses